ArticleClinical case reports2015
Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.
Article in Clinical case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 37 citations in OpenAlex.
- Pathophysiology, Treatment, and Prognosis of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome: A Review.Current issues in molecular biology · 2024Review
- Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.HemaSphere · 2023Article
- International definition of iMCD-TAFRO: future perspectives.Journal of clinical and experimental hematopathology : JCEH · 2022Article
- Borderline Case of TAFRO Syndrome and POEMS Syndrome.Internal medicine (Tokyo, Japan) · 2021Article
- An Autopsy Case of TAFRO Syndrome with Type II Respiratory Failure.The American journal of case reports · 2020Article
- Ascites in the "TAFRO" Syndrome: Does the Squeeze Make the Juice?Digestive diseases and sciences · 2020Article
- Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.Journal of cancer research and clinical oncology · 2020Article
- International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.Blood · 2018Article
- Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.Internal medicine (Tokyo, Japan) · 2018Article
- TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.CEN case reports · 2018Article
- TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.Internal medicine (Tokyo, Japan) · 2018Article
- Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated withRenal replacement therapy · 2018Article
- TAFRO syndrome: current perspectives.Journal of blood medicine · 2018Review
- Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.Medicine · 2017Article
- Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.Internal medicine (Tokyo, Japan) · 2017Review
- Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome.CEN case reports · 2017Article
- Article
- Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.Internal medicine (Tokyo, Japan) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
TAFRO syndrome have been proposed as a rare variant of Castleman's disease. This article reports a case of a 56-year-old man with TAFRO syndrome who was successfully treated with thalidomide in spite of the refractoriness to prednisolone and tocilizumab. Thalidomide may be one of the treatment options for TAFRO syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.